E
ABVC BioPharma, Inc. ABVC
$0.911 $0.0354.00% NASDAQ
Recommendation
Prev Close
$0.876
Volume
119,793
Avg Vol (90D)
566,502
Market Cap
$13.18M
Dividend & Yield
--
52-Week Range
$0.40 - $1.73
P/E (TTM)
--
EPS (TTM)
-$0.4966
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
ABVC BioPharma Inc Reports Q4 2024 Earnings: Revenue Surges to $509,589, EPS Improves to $(0.42)
4/16/2025 - GuruFocus
ABVC BioPharma Reports Strong Financial Growth
4/15/2025 - TipRanks Financial Blog
ABVC BioPharma (NASDAQ:ABVC) Trading Up 0.4% - What's Next?
3/9/2025 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Decrease in Short Interest
2/14/2025 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest
1/29/2025 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 148.2% in December
12/27/2024 - Ticker Report
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, ...
12/19/2024 - GuruFocus
ABVC BioPharma believes ABV-1504 can fill void in market after Prozac
12/19/2024 - TipRanks Financial Blog
ABVC BioPharma believes ABV-1504 can fill void in market after Prozac
12/19/2024 - The Fly
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21
12/19/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest
12/14/2024 - Ticker Report
ABVC BioPharma gets $200K in cash from OncoX BioPharma
12/11/2024 - Seeking Alpha - Healthcare
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, ...
12/11/2024 - GuruFocus
ABVC BioPharma receives $200,000 cash payment from OncoX
12/11/2024 - The Fly
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
12/11/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Increase in Short Interest
11/30/2024 - Ticker Report
ABVC BioPharma reports Q3 EPS (2c) vs (82c) last year
11/14/2024 - The Fly
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
11/14/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Growth in Short Interest
11/14/2024 - Ticker Report
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb
10/22/2024 - Seeking Alpha - Healthcare
ABVC BioPharma receives $50,000 in incremental licensing fees
10/22/2024 - The Fly
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
10/22/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Update
10/14/2024 - Ticker Report
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Decreases By 19.1%
9/28/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
$509.60K
EBITDA (TTM)
-$4.70M
EBIT (TTM)
-$4.73M
Net Income (TTM)
-$4.90M
Balance Sheet
Total Assets (Q)
$7.54M
Total Debt (Q)
$3.20M
Total Liabilities (Q)
$6.82M
Book Value Per Share (Q)
$0.0933
Cash Flow
Cash from Operations (TTM)
-$1.81M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$1.98M
Net Change in Cash (TTM)
$147.00K
Filings
Filing Date
Tuesday, April 15, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
-0.33
7-Day Total Return
-0.95%
30-Day Total Return
30.87%
60-Day Total Return
70.28%
90-Day Total Return
75.26%
Year to Date Total Return
42.06%
1-Year Total Return
-38.45%
2-Year Total Return
-86.23%
3-Year Total Return
-96.12%
5-Year Total Return
-97.15%
52-week Low
Feb 10, 2025 - $0.40
52-week High
Apr 25, 2024 - $1.73
Valuation
Market Cap
$13.18M - Nano Cap
Enterprise Value
$15.56M
Price/Sales (TTM)
22.75
Price/Book (Q)
9.39
Dividends and Shares
Shares Outstanding
13.20M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.abvcpharma.com
Phone Number
510 668 0881
Address
44370 Old Warm Springs Boulevard
Fremont, CA 94538
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which... more
NASDAQ 04/24/2025 4:00PM Eastern Quotes delayed